Piccolo, Raffaele; Bonaa, Kaare H.; Efthimiou, Orestis; Varenne, Olivier; Urban, Philip; Kaiser, Christoph; Räber, Lorenz; de Belder, Adam; Remkes, Wouter; Van’T Hof, Arnoud W. J.; Stankovic, Goran; Lemos, Pedro A.; Wilsgaard, Tom; Reifart, Jörg; Rodriguez, Alfredo E.; Ribeiro, Expedito E.; Serruys, Patrick W. J. C.; Abizaid, Alex; Sabaté, Manel; Byrne, Robert A.; de la Torre Hernandez, Jose M.; Wijns, William; Esposito, Giovanni; Jüni, Peter; Windecker, Stephan; Valgimigli, Marco (Journal article; Tidsskriftartikkel; Peer reviewed, 2021-10-08)
Background - New‐generation drug‐eluting stents (DES) reduce target‐vessel revascularization compared with bare‐metal stents (BMS), and recent data suggest that DES have the potential to decrease the risk of myocardial infarction and cardiovascular mortality. We evaluated the treatment effect of DES versus BMS according to the target artery (left anterior descending [LAD] and/or left main [LM] versus ...